• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, November 17, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

CREMA Framework Recovers High Clonal Fraction Mosaic Chromosomal Alterations

by
November 12, 2026
in Biology, Technology
Reading Time: 4 mins read
0
CREMA Framework Recovers High Clonal Fraction Mosaic Chromosomal Alterations

CREMA Framework Recovers High Clonal Fraction Mosaic Chromosomal Alterations

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A standalone post-processing framework termed CREMA has been developed to recover high clonal fraction mosaic chromosomal alterations that are systematically overlooked by conventional phase-based detection algorithms. Published in BMC Bioinformatics by Weiyin Zhou, Mitchell J. Machiela, and colleagues, the computational pipeline identifies and classifies these previously undetected somatic events by interrogating candidates derived from runs of homozygosity or alternative segmentation outputs. Across genomic evaluation sets, this workflow successfully captured high clonal fraction alterations—predominantly copy-neutral loss of heterozygosity—that were absent from existing phase-based call sets, addressing a critical blind spot in current clonal hematopoiesis characterization.

Mosaic chromosomal alterations, recognized as a form of clonal hematopoiesis, comprise large somatic gains, losses, and copy-neutral chromosomal rearrangements. These structural genomic events correlate closely with age-related genomic instability as well as an increased susceptibility to cancer. In standard genomic workflows, phase-based detection pipelines such as MoChA demonstrate high sensitivity when identifying alterations present at low clonal fractions, effectively resolving mosaic events that exist in as few as approximately one percent of sampled blood cells. This sensitivity is achieved primarily by leveraging long-range haplotype imbalance across phased heterozygous positions throughout the genome.

Despite the sensitivity of phase-based strategies for low-frequency events, these methods encounter fundamental technical limitations when the clonal fraction of an alteration becomes very high. In cells exhibiting elevated clonal fractions, allelic imbalance becomes pronounced and extreme, leading phase-informative heterozygous genotypes to be erroneously misclassified as homozygous sites. This miscalling undermines phase-based detection models and sharply reduces analytical sensitivity, presenting a particularly severe impediment for high clonal fraction copy-neutral loss of heterozygosity. Because copy-neutral loss of heterozygosity retains a near-normal log R ratio, it lacks abnormal copy-number signal and closely mimics constitutional autozygosity, evading standard detection despite carrying elevated clinical significance.

The inability to reliably capture high clonal fraction alterations presents a critical diagnostic gap, as these high-burden somatic events are more prone to manifest in observable phenotypic consequences and confer elevated risks for hematologic malignancies. To resolve this blind spot, the investigators engineered CREMA, an acronym for Clonal Recovery using Expectation-Maximization Algorithms. Functioning as a standalone post-processing architecture, CREMA accepts candidate genomic regions identified through runs of homozygosity or related segmentation tools, subjecting these nominated intervals to rigorous statistical re-examination rather than relying exclusively on haplotype phase continuity.

At the core of the CREMA analytical pipeline is a multi-step quantitative modeling routine that directly examines raw signal properties across nominated candidate segments. The framework first recenters the log R ratio to account for baseline shifts, and then models the central distribution of B-allele frequency metrics using expectation-maximization algorithms. CREMA evaluates these distributions by selecting between one-band and two-band statistical models based on the Akaike information criterion. Following model selection, the framework executes a specialized geometric classifier operating within a joint coordinate space defined by log R ratio values and B-allele frequency-derived clonal fraction estimates, thereby categorizing the specific structural nature of each candidate event.

Validation across distinct clinical and population cohorts demonstrated the framework’s capacity to rescue large somatic alterations that escaped detection by the phase-based MoChA pipeline. The most pronounced performance gain occurred within a myelofibrosis patient cohort characterized by high clonal fraction copy-neutral loss of heterozygosity on chromosome 9p encompassing the JAK2 gene region. In this disease cohort, combining runs of homozygosity nomination with CREMA post-processing identified 232 additional copy-neutral loss of heterozygosity events. This addition represented an 11.1 percent expansion in the total yield of autosomal mosaic chromosomal alterations spanning at least two megabases.

In these population cohorts, the pipeline isolated smaller, targeted sets of additional high clonal fraction copy-neutral loss of heterozygosity events, contributing increases of 0.5 percent and 0.4 percent to the respective autosomal mosaic chromosomal alteration call sets. These empirical results demonstrate that while the magnitude of recovery depends on underlying cohort characteristics, the workflow systematically captures somatic alterations missed by phase-dependent tools across both targeted disease groups and broad population samples.

Ultimately, the researchers concluded that CREMA serves as an effective complement to phase-based mosaic chromosomal alteration detection methodologies. By decoupling initial candidate generation—via runs of homozygosity or independent segmentation algorithms—from candidate-level classification via expectation-maximization modeling of B-allele frequency and log R ratio distributions, the workflow resolves the specific vulnerabilities that hinder phase-based calls. While primarily resolving copy-neutral loss of heterozygosity where log R ratio remains neutral, CREMA remains broadly applicable to the identification and classification of high clonal fraction somatic copy gains and losses.

Subject of Research: Recovery of high clonal fraction mosaic chromosomal alterations using CREMA

Article Title: CREMA: recovery of high clonal fraction mosaic chromosomal alterations missed by phase-based detection

Article References: Zhou, W., Gadalla, S. M., Rafati, M., Spellman, S. R., Huang, W.-Y., Freedman, N. D., & Machiela, M. J. (2026). CREMA: recovery of high clonal fraction mosaic chromosomal alterations missed by phase-based detection. BMC Bioinformatics. https://doi.org/10.1186/s12859-026-06751-2

Image Credits: AI Generated

DOI: 10.1186/s12859-026-06751-2

Keywords: mosaic chromosomal alterations, clonal hematopoiesis, CREMA, copy-neutral loss of heterozygosity, runs of homozygosity, B-allele frequency, log R ratio, expectation-maximization algorithm, Akaike information criterion, MoChA, phase-based detection, myelofibrosis, JAK2, PLCO datasets, genomic instability, hematologic malignancies

News Source: Gregory Coleman. (November 12, 2026). CREMA Framework Recovers High Clonal Fraction Mosaic Chromosomal Alterations. Scienmag.

Tags: Akaike information criterionB-allele frequencyclonal hematopoiesiscopy-neutral loss of heterozygosityCREMAexpectation-maximization algorithmgenomic instabilityHematologic malignanciesJAK2log R ratioMoChAmosaic chromosomal alterationsmyelofibrosisphase-based detectionPLCO datasetsruns of homozygosity
Share12Tweet7Share2ShareShareShare1

Related Posts

Proposed Biogas Systems Could Cut Egyptian Household Energy Costs by 35–40%

Proposed Biogas Systems Could Cut Egyptian Household Energy Costs by 35–40%

November 17, 2026
Pervious Concrete With Coal Waste and Sawdust Filters Urban Stormwater Runoff

Pervious Concrete With Coal Waste and Sawdust Filters Urban Stormwater Runoff

November 17, 2026

Discrete-Time Geometric Backstepping Improves Aggressive Quadrotor Trajectory Tracking

November 17, 2026

Nanocomposite Architecture Design Critical for High-Performance Energy Conversion and Storage

November 17, 2026

POPULAR NEWS

  • High Prevalence of Gender-Based Violence Follows Armed Conflict in Southern Tigray

    High Prevalence of Gender-Based Violence Follows Armed Conflict in Southern Tigray

    29 shares
    Share 12 Tweet 7
  • Air Pollutants Tied to Adverse Sleep Outcomes Amid Notable Evidence Uncertainty

    29 shares
    Share 12 Tweet 7
  • Network Analysis Identifies Core Positive Development Attributes in Rural Chinese Adolescents

    29 shares
    Share 12 Tweet 7
  • China Silver Economy Policies Show Good Overall Consistency but Uneven Regional Breadth

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Professional Footballers Experience Sustained Career Declines After ACL Reconstruction

Postoperative Alignment Influences Long-Term Knee Revision Risk Following High Tibial Osteotomy

Proposed Biogas Systems Could Cut Egyptian Household Energy Costs by 35–40%

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.